2
TABLE II.
Vaccines supplied during first quarter, 1921.
Serial number. |
Nature of vaccine. | Number of doses of autogenous vaccine. |
Number of doses of stock vaccine. |
Total. |
1 | Staphylococcus | 186 | 358 | 544 |
2 | Streptococcus | 166 | 217 | 383 |
3 | Acne bacillus | ... | 13 | 13 |
4 | Pemphigus | ... | 63 | 63 |
5 | Gonococcus | 6 | 1,287 | 1,293 |
6 | Pneumococcus | 173 | 78 | 251 |
7 | Influenza (curative) | ... | 63 | 63 |
8 | Influenza (prophylactic) | ... | 223 | 223 |
9 | Compound catarrhal | 12 | 27 | 39 |
10 | Tuberculin | ... | 90 | 90 |
11 | Bacillus Coli | 82 | 86 | 168 |
12 | Dysentery | ... | ... | ... |
13 | Choleræ | ... | 736 | 736 |
14 | Typhoid | ... | ... | ... |
15 | T.A.B. vaccine | ... | 740 | 740 |
16 | Other vaccines | 12 | ... | 12 |
Total | 637 | 3,981 | 4,618 |
Autogenous vaccines.
Autogenous vaccines were prepared for 83 cases. The results of treat-
ment have not been obtained for over 50 per cent of the cases for which the
vaccines were prepared. It is to be regretted that the returns for a larger
percentage of these vaccines are not received. A list of the different autogenous
vaccines made during the quarter is given in table III.
TABLE III.
Autogenous vaccines made during the first quarter, 1921.
Class of cases. | Number of vaccines made. |
Result. | Not used or not reported. | ||
Cured. | Improved. | No effect. | |||
Furunculosis | 2 | 1 | ... | ... | 1 |
Eczema, pemphigus and skin eruptions | 8 | 1 | 1 | 2 | 4 |
Abscesses, carbuncles and cellulitis | 14 | 4 | 1 | 1 | 8 |
Pyorrhœa alveolaris | 4 | ... | 1 | 1 | 2 |
Inflammation of the mouth, throat, nose, ear and con- junctivæ |
11 | ... | 1 | 3 | 7 |
Asthma, bronchitis and lung affections | 20 | 1 | 2 | 5 | 12 |
Diseases of the urinary tract | 2 | ... | ... | ... | 2 |
Septic wounds and sinuses | 1 | ... | ... | ... | 1 |
Puerperal sepsis | 1 | ... | ... | ... | 1 |
Miscellaneous | 20 | 3 | 6 | 2 | 9 |
Total | 83 | 10 | 12 | 14 | 47 |